Comprehensive Library Of Resveratrol News

Subscribe to our newsletter to receive email notifications when new articles are posted.


  • IRON-CHELATING MOLECULES IN APPLES PROLONG LIFE OF ROUNDWORMS

    December 15, 2010: by Bill Sardi


    Apple polyphenols extend life in roundworms similar to resveratrol, which points to small molecules that control iron and copper as exerting these life-prolonging effects.  Resveratrol is solely a copper chelator but also controls iron indirectly.  This report further substantiates the over-mineralization theory of aging.

    Read the whole post »

  • Cell Study Shows Inhibition of SIRTUIN1-Gene Protein Protects Brain Cells That Produce Dopamine

    December 12, 2010: by Bill Sardi


    Since 2003 when a Harvard researcher extolled the SIRTUIN1 gene as the holy grail of anti-aging, this gene has only diminished in its stature.  Out of a library of about 25,000 human genes, about 832 are believed to be involved in producing longevity as evidence in calorie-restricted animals whose lifespan is approximately doubled.  Longevity involves many genes, not a sole gene target.

    Resveratrol, the red wine molecule, which has been claimed to stimulate the SIRTUIN1 gene to produce proteins, has been shown to protect brain cells in models of Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (Lou Gehrig’s disease).

    Read the whole post »

  • Importance of low-dose resveratrol

    December 1, 2010: by ResveratrolNews


    Human and Experimental Toxicology, 29(12) 1016–1017

    Commentary on ‘Resveratrol commonly displays hormesis: Occurrence and biomedical significance’

    Dipak K Das
    Cardiovascular Research Center, University of Connecticut, Farmington, CT, USA

    Abstract

    Resveratrol, a grape skin and red wine-derived polyphenolic phytoalexin, exhibits hormetic action delivering numerous health benefits at lower doses while being detrimental at higher doses. Epidemiologic and clinical trials need to be based on the clear understanding of hormetic health benefits of resveratrol.

    Read the whole post »

  • Headline Today: Telomerase Agent Restores Youth In Genetically-Altered Mice

    November 29, 2010: by Bill Sardi


    Harvard scientists say they have successfully restored youthfulness to old mice by re-activating telomerase in telomerase-deficient mice (telomerase is the enzyme that repairs the end-caps of chromosomes known as telomeres).  In just one month of telomerase therapy “aged, mice, equivalent to 80-year-old humans, and were about to pass away,” were restored to “the physiological equivalent of young adults.” The report emanates from Nature Magazine today.

    As spectacular as this laboratory study is, the question remains whether an experiment where mice are genetically bred to age prematurely applies to human aging.  At the genetic level, human aging appears to largely involve epigenetics (switching of the TERT gene), not gene mutation as in the case of these mutated laboratory mice.

    However, there are remarkable findings in this report that go overlooked.  The youthful changes in these mice (their shrinking brains and sperm-producing glands got bigger, and their sense of smell returned) correlated with the lengthening of telomeres.  These changes were obviously produced via epigenetic changes that countered inbred (mutational) factors.  That should have been the real headline.  Man’s biological destiny may not be permanently locked in his genes.

    Read the whole post »

  • Aging And Iron

    November 28, 2010: by Bill Sardi


    Eugene D. Weinberg PhD is emeritus professor in biology at Indiana University and long-time authority on iron overload.  His recent landmark paper, entitled The Hazards Of Iron Loading, published in the November issue of Metallomics (Volume 2, pages 732–740, 2010), provides authoritative evidence for the predominant role of iron in human aging.

    Consider some of the striking facts that Dr. Weinberg presents in his report:

    Read the whole post »

  • While Pharmacologists Race To Develop Drug That Inhibits Protein That Produces Brain Plaque, Resveratrol Already Does That

    November 20, 2010: by Bill Sardi


    Comment: for all resveratrol-followers out there, researchers find that activation of the 5-lipoxygenase gene is key to the formation of beta amyloid plaque formation in the brain, thought to be involved in Alzheimer’s disease.  While there is no available drug specifically designed to inhibit 5-lipoxygenase, resveratrol, a natural enzyme inhibitor and metal (copper) chelator, inhibits 5-lipoxygenase.

    Read the whole post »

  • Longevinex® Activates Sirtuin3 – A Gene Found To Be Essential In Producing The Beneficial Health Effects Of A Longevity (Calorie-Restricted) Diet

    November 19, 2010: by Bill Sardi


    Mice lacking the Sirtuin3 gene develop hearing loss via the production of free radicals that damage the power plants (mitochondria) within living cells, said researchers in a newly published report in the journal CELL today.

    Researchers report the Sirtuin3 gene is essential in producing the health and longevity effects of a limited calorie diet. The Sirtuin3 gene increases antioxidant activity (glutathione, pronounced glu-tah-thigh-on) in mitochondrial compartments within living cells, thus preventing age-related hearing loss. The mitochondria are small organelles that a found within living cells that produce cellular energy in the form of adenosine triphosphate (ATP).

    So far Sirtuin3 has taken a back seat to Sirtuin1 in longevity research, but possibly the entire family of Sirtuin “survival genes” will eventually be linked to longevity mechanisms. The entire research report can be viewed here.

    Read the whole post »

  • Harvard Researcher Says He Will Soon Reveal A Protein Partner That Is Required To Make The Sirtuin1 Longevity Gene Work

    November 18, 2010: by Bill Sardi


    In a feature article appearing in Australian Life Scientist entitled “The Science of Longevity: Resveratrol and Beyond,” Harvard biologist and longevity researcher David Sinclair PhD, whose research studies involving the activation of the Sirtuin1 longevity gene by the red wine molecule resveratrol have been recently called into question, now says he will soon reveal a “protein partner that is part of the mechanism,” a protein which explains why resveratrol works in some laboratory studies and not in others.

    The article in Life Scientist says Sinclair is keeping the details of this protein partner “close to his chest,” he will be revealing it at the Australian Health & Medical Research Congress now underway.  Sinclair says “We’ve found the missing piece to the puzzle that will make sense of all the data they’re arguing about, a piece people haven’t realized was missing…. People didn’t know you need to add it for it to be physiologically relevant.”

    Read the whole post »

  • New study: Longevinex® Activates Youthful Mechanisms

    November 16, 2010: by Bill Sardi


    Low-Dose Longevinex® Re-Activates Youthful Mechanisms In Animal Hearts – Confirms Longevity Effects

    Las Vegas, NV (Nov. 16, 2010) – University-based researchers report today in the Canadian Journal of Physiology & Pharmacology that a resveratrol-based nutriceutical (Longevinex®) induces longevity effects at low dose in laboratory animals.

    Also, as expected, Longevinex® (pronounced long-jev-in-ex) limited damage to the heart after an intentionally-induced heart attack. Longevinex® reduced the size of the experimentally-induced heart attack from 37% to 23% of heart tissue, sufficient for the heart to survive this adverse event. There was markedly less scar tissue (fibrosis) following the heart attack. If the results of this animal study are applicable to humans, many thousands of heart-attack victims would avert a mortal outcome by taking a daily pill to protect their heart.

    It’s possible a red wine pill like Longevinex® could replace aspirin since half of the patients who experience a mortal heart seizure were taking aspirin on the day of their demise. Low-dose (81 mg) aspirin isn’t working, and high-dose (325 mg) aspirin produces offsetting side effects.

    Read the whole post »

  • Longevinex® Favorably Improves Cholesterol

    November 9, 2010: by Bill Sardi


    Longevinex® Produces Heart-Healthiest Laboratory Rats In The World; Nutriceutical Has Profound Effect Upon Cholesterol-Fed Animals.

    Las Vegas, NV (November 8, 2010) – According to the latest published research, the heart-healthiest laboratory animals in the world are taking Longevinex®, a red wine pill dietary supplement.

    Researchers gave cholesterol-fed rabbits Longevinex®, a proprietary blend of red wine molecules (resveratrol, quercetin, ferulic acid) plus rice bran IP6 and vitamin D3, and found this dietary supplement:

    • More than halves circulating total cholesterol among cholesterol-fed animals.
    • Cuts arterial plaque (the stuff that sticks to artery walls) by more than half.
    • Reduces the area of damage to the heart following heart attack by 30%-40%, thus sparing the animal’s life.
    • Improves the heart-pumping action of the heart following a heart attack.
    • Improves blood flow in both the aorta (first blood vessel outside the heart) and in the four coronary arteries that supply the heart with oxygenated blood, following an intentionally-induced heart attack.

    Read the whole post »

« Previous Entries Next Entries »